Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Indicat în schemele de tratament al mielomului multiplu.

Indicat în schemele de tratament ale adenocarcinomului ovarian avansat.

Indicat în schemele de tratament al cancerului de sân avansat.

Indicat în schemele de tratament a policitemia vera.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L01AA03 MELPHALANUM COMPR. FILM. 2 mg

ALKERAN 2 mg 2 mg THE WELLCOME FOUNDATION

LTD.

________________________________________________________________________________
______________________________________________________________________________

| 709 |L01AA06| IFOSFAMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF. 1 g

HOLOXAN 1 g 1 g BAXTER ONCOLOGY GMBH
L01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF. 2 g

HOLOXAN 2 g 2 g BAXTER ONCOLOGY GMBH

L01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF. 500 mg

HOLOXAN 500 mg 500 mg BAXTER ONCOLOGY GMBH

________________________________________________________________________________
______________________________________________________________________________

| 710 |L01AB01| BUSULFANUM | |

|_______|_______|____________________________________________|_________________|
NOTĂ: